Articles

Title

Date Published

Staged repair for a chronic dissecting thoracic aortic aneurysm with no transfusion in a Jehovah’s Witness patient.

June 1, 2007

Planning for pandemic influenza: effect of a pandemic on the supply and demand for blood products in the United States.

June 1, 2007

Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology.

June 1, 2007

Efficacy of allogeneic red blood cell transfusions.

June 1, 2007

Volume Replacement Therapy during Major Orthopedic Surgery Using Voluven(R) (Hydroxyethyl Starch 130/0.4) or Hetastarch.

June 1, 2007

Blood transfusion and risk of metastatic disease or recurrence in patients undergoing immediate TRAM flap breast reconstruction: a clinical study and meta-analysis.

June 1, 2007

The coagulation changes induced by rapid in vivo crystalloid infusion are attenuated when magnesium is kept at the upper limit of normal.

June 1, 2007

The impact of storage on red cell function in blood transfusion.

June 1, 2007

Improved coagulation and blood conservation in the golden hours after cardiopulmonary bypass.

June 1, 2007

Red blood cell (RBC) age at collection and storage influences RBC membrane-associated carbohydrates and lectin binding.

June 1, 2007

Use of blood and blood products in trauma.

June 1, 2007

Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.

June 1, 2007

Hemopure transfusion in a child with severe anemia.

June 1, 2007

Pathophysiology of TRALI: current concepts.

June 1, 2007

Blood management issues using blood management strategies.

June 1, 2007

TRALI–definition, mechanisms, incidence and clinical relevance.

June 1, 2007

Alternatives to allogeneic blood transfusions.

June 1, 2007

Effect of recombinant human interleukin 11 on the platelet after hematopoietic stem cell transplantation in patients with leukemia.

June 1, 2007

Allogeneic red blood cell transfusion: physiology of oxygen transport.

June 1, 2007

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist.

June 1, 2007